Acadian Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-41,300
| Closed | -$502K | – | 1627 |
|
|
2016
Q1 | $502K | Sell |
41,300
-190,878
| -82% | -$2.32M | ﹤0.01% | 752 |
|
|
2015
Q4 | $3.69M | Buy |
232,178
+186,162
| +405% | +$2.96M | 0.02% | 447 |
|
|
2015
Q3 | $705K | Sell |
46,016
-829,938
| -95% | -$12.7M | ﹤0.01% | 731 |
|
|
2015
Q2 | $21.3M | Sell |
875,954
-139,435
| -14% | -$3.39M | 0.1% | 195 |
|
|
2015
Q1 | $23.6M | Sell |
1,015,389
-212,378
| -17% | -$4.94M | 0.11% | 188 |
|
|
2014
Q4 | $30.8M | Buy |
1,227,767
+661,427
| +117% | +$16.6M | 0.14% | 164 |
|
|
2014
Q3 | $17.6M | Buy |
566,340
+175,850
| +45% | +$5.47M | 0.09% | 215 |
|
|
2014
Q2 | $10.1M | Buy |
390,490
+368,679
| +1,690% | +$9.54M | 0.05% | 284 |
|
|
2014
Q1 | $510K | Sell |
21,811
-126,800
| -85% | -$2.96M | ﹤0.01% | 670 |
|
|
2013
Q4 | $3.77M | Sell |
148,611
-58,818
| -28% | -$1.49M | 0.02% | 378 |
|
|
2013
Q3 | $4.23M | Buy |
+207,429
| New | +$4.23M | 0.03% | 339 |
|